SPM 962

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
6	パーキンソン病	24

6. パーキンソン病

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

trials per page:

Showing 1 to 10 of 24 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01631825 (ClinicalTrials.gov)	October 2009	25/6/2012	A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients	An Open-label Long-term Extension Trial From Phase III of SPM962 (243-08-002) in Advanced Parkinson' ...	Parkinson's Disease	Drug: SPM 962	Otsuka Pharmaceutical Co., Ltd.	NULL	Completed	N/A	N/A	All	321	Phase 3	Japan
2	NCT01628926 (ClinicalTrials.gov)	June 2009	24/6/2012	A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients	A Double-Blind, 3-Arm, Parallel Group, Placebo- and Ropinirole-Controlled Study for SPM 962in Advanc ...	Parkinson's Disease	Drug: SPM 962;Drug: Ropinirole;Drug: Placebo	Otsuka Pharmaceutical Co., Ltd.	NULL	Completed	30 Years	79 Years	All	420	Phase 3	Japan
3	JPRN-JapicCTI-090888	01/4/2009		A Double-Blind, 3-Arm, Parallel Group, Placebo-and Ropinirole-Controlled Study of SPM 962in Subjects ...	A Double-Blind, 3-Arm, Parallel Group, Placebo-and Ropinirole-Controlled Study of SPM 962in Subjects ...	Parkinson's Disease Treated Concomitantly with L-dopa	Intervention name : SPM 962 Dosage And administration of the intervention : SPM 962: transdermal appl ...	Otsuka Pharmaceutical Co., Ltd.	NULL		30	79	BOTH	400	Phase 3	NULL
4	EUCTR2004-000148-26-AT (EUCTR)	31/12/2008	26/11/2008	A multi-centre, multinational, phase 3, open-label extension trial to assess the safety of long-term ...	A multi-centre, multinational, phase 3, open-label extension trial to assess the safety of long-term ...	Parkinson's Disease	Product Name: Rotigotine Product Code: SPM 962 INN or Proposed INN: Rotigotine Other descriptive name: ...	Schwarz BioSciences Inc.	NULL	Not Recruiting			Female: yes Male: yes	360	Phase 3	Czech Republic;Hungary;Finland;Spain;Austria;Italy;Sweden
5	EUCTR2004-000148-26-HU (EUCTR)	26/07/2008	19/07/2004	A multi-centre, multinational, phase 3, open-label extension trial to assess the safety of long-term ...	A multi-centre, multinational, phase 3, open-label extension trial to assess the safety of long-term ...	Parkinson's Disease	Product Name: Rotigotine Product Code: SPM 962 INN or Proposed INN: Rotigotine Other descriptive name: ...	Schwarz BioSciences Inc.	NULL	Not Recruiting			Female: yes Male: yes	360	Phase 3	Finland;Hungary;Czech Republic;Spain;Italy;Sweden
6	NCT01628965 (ClinicalTrials.gov)	January 2008	25/6/2012	A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients	An Open-label Long-term Extension Trial From Phase II/III of SPM962 (243-07-001) in Early Parkinson' ...	Parkinson's Disease	Drug: SPM 962	Otsuka Pharmaceutical Co., Ltd.	NULL	Completed	N/A	N/A	All	143	Phase 2/Phase 3	Japan
7	EUCTR2006-006907-35-IT (EUCTR)	19/12/2007	20/04/2007	A multicenter, multinational, phase 3b, open label extension trial, to evaluate the long term effect ...	A multicenter, multinational, phase 3b, open label extension trial, to evaluate the long term effect ...	Patient with Idiopathic Parkinson Diesease MedDRA version: 9.1;Level: LLT;Classification code 100615 ...	Product Name: rotigotine INN or Proposed INN: rotigotine	SCHWARZ PHARMA	NULL	Not Recruiting			Female: yes Male: yes	270	Phase 3	Hungary;Finland;United Kingdom;Germany;Spain;Italy;Austria
8	NCT00537485 (ClinicalTrials.gov)	September 2007	27/9/2007	A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease Patients	A Placebo-controlled Study for SPM 962in Early Parkinson's Disease Patients With Non-concomitant Tre ...	Early Parkinson's Disease	Drug: SPM 962;Drug: placebo	Otsuka Pharmaceutical Co., Ltd.	NULL	Completed	30 Years	79 Years	All	180	Phase 2/Phase 3	Japan
9	NCT01631812 (ClinicalTrials.gov)	December 2006	25/6/2012	A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease Patients	An Open-label Long-term Extension Trial From Late Phase II of SPM962 (243-05-001) in Advanced Parkin ...	Parkinson's Disease	Drug: SPM 962	Otsuka Pharmaceutical Co., Ltd.	NULL	Completed	N/A	N/A	All	130	Phase 2	Japan
10	NCT01628848 (ClinicalTrials.gov)	August 2006	24/6/2012	A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients	A Placebo-controlled Dose-finding Study for SPM 962in Advanced Parkinson's Disease Patients With Con ...	Parkinson's Disease	Drug: SPM 962;Drug: Placebo	Otsuka Pharmaceutical Co., Ltd.	NULL	Completed	30 Years	79 Years	All	174	Phase 2	Japan

First Previous1 2 3Next Last